Shoulder Injury Related to Vaccine Administration.
Citation: Journal of the American Academy of Orthopaedic Surgeons. 29(17):732-739, 2021 Sep 01.PMID: 34185028Institution: MedStar Washington Hospital CenterDepartment: Orthopaedic Surgery ResidencyForm of publication: Journal ArticleMedline article type(s): Journal ArticleSubject headings: *Rotator Cuff Injuries | *Shoulder Injuries | *Vaccines | Humans | Shoulder | Shoulder Pain | Vaccination/ae [Adverse Effects] | Vaccines/ae [Adverse Effects]Year: 2021Local holdings: Available online from MWHC library: Oct 1993 - present, Available in print through MWHC library: 1999 - presentISSN:- 1067-151X
- Keeling, Laura E:
- https://orcid.org/0000-0001-7776-6635
Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Journal Article | MedStar Authors Catalog | Article | 34185028 | Available | 34185028 |
Available online from MWHC library: Oct 1993 - present, Available in print through MWHC library: 1999 - present
Shoulder injury related to vaccine administration (SIRVA) is a rare yet increasingly recognized complication of immunization. Although a medicolegal term rather than a true diagnosis, SIRVA was introduced in 2010 by the Vaccine Injury Compensation Program after an increase in claims filed for vaccine-related shoulder injury. Patients typically present with severe pain and limited range of motion within 48 hours of vaccination and may experience notable functional limitations. Although the underlying pathophysiology is incompletely understood, the existing literature suggests that SIRVA results from the inflammatory response produced when the vaccine is injected into tissues containing a preexisting antibody. Current treatment modalities include physical therapy, corticosteroid injections, and antiinflammatory medications. In some cases, surgery may be required to treat underlying pathology, such as rotator cuff or biceps tendinopathy. Although the available literature indicates modest improvement in patients with SIRVA undergoing treatment, current data are limited to case series. Larger, high-quality studies are needed to determine the natural history and optimal treatment of this increasingly prevalent condition. Copyright (c) 2021 by the American Academy of Orthopaedic Surgeons.
English